Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Insurance Genetic Testing topic
No spam. Unsubscribe anytime.
Senate passes Susan G. Komen-backed bill to cover genetic testing, imaging for those at increased cancer risk
Summary
Senate Bill 109, described on the floor as a Susan G. Komen request bill, would require health plans offered or renewed in the state to provide coverage for genetic testing and certain cancer imaging for individuals at increased risk. The Senate passed the bill 35-8 after debate over costs and scope.
The Oklahoma Senate approved Senate Bill 109, a request measure described on the floor as coming from Susan G. Komen, to expand health-insurance coverage for genetic testing and cancer imaging for individuals identified as at increased risk. The bill passed final reading by a recorded vote of 35 ayes to 8 nays.
Sponsor Senator Stanley described the bill as intended to "ensure that Oklahomans have access to life saving genetic testing and cancer imaging without financial barriers," arguing that early detection improves outcomes and reduces long-term treatment costs.
What the bill requires
As presented on the floor, the bill directs that health benefit plans "offered, issued, or renewed in this state on or after the effective date" provide coverage for genetic tests and cancer imaging for individuals identified as having elevated risk by a clinician. The bill text cited an explicit exception on prenatal conditions during several exchanges: the sponsor reiterated that the measure "is not covering prenatal conditions" and said the focus is on people with a family history of cancer who consult their physician.
Fiscal impact and administration
The sponsor noted a modest fiscal estimate communicated late in the process, identifying an administrative cost estimate of about $150,000. The sponsor described that as a minimal, one-time cost to implement the coverage changes and related administration for state employee plans.
Debate highlights
Opponents raised questions about whether the requirement would increase insurance premiums and about unintended scope, including whether prenatal or pre-implantation testing could be implicated. Senator Jett warned that broad mandates can raise insurance costs; Senator Guthrie said the bill "may have good intentions, but it will raise health insurance costs for all Oklahomans." The sponsor and supporters countered that early detection can reduce long-term costs of cancer care and that the bill is optional for patients (coverage would be available when clinically indicated), not a state-run testing mandate.
Some senators asked whether insurers could use genetic results to deny coverage; the sponsor responded that protections under federal law (discussed in floor exchange as the Affordable Care Act of 2010) prevent denial of coverage for preexisting conditions.
Final action
After floor debate, the Senate approved the bill on final reading, 35 to 8, and the measure was declared passed. Supporters framed the measure as an expansion of preventive care for families with a cancer history; opponents urged caution about downstream cost and privacy implications.
